Brind.

Kevin Koch is the President and CEO of a company (Q115270940), which announced on August 7, 2025, the completion of ARCH and CANYON studies in Boulder, Colo.

3 reports, 2 independent Updated Sep 22
Gone quiet
Reports
3
Developments
1
Repetition
67%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Kevin Koch is the President and CEO of a company (Q115270940), which announced on August 7, 2025, the completion of ARCH and CANYON studies in Boulder, Colo.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • prnewswire.com
  • PR NewswireEdgewise Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights – Announced positive top-line data from the open-label extension MESA trial of sevasemten in partici
1 more outlet ran the same wire story